Semaglutide significantly reduces 'food noise' in US adults by 42% for weight management
Background
Food noise, characterized by persistent and intrusive thoughts about food, is a significant concern for individuals with obesity, often impairing quality of life and hindering weight management efforts. Current weight loss strategies frequently overlook this psychological burden, focusing primarily on caloric restriction or physical activity. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) like semaglutide have shown remarkable efficacy in weight reduction, but their impact on the subjective experience of food-related thoughts, a crucial aspect of patient well-being, remains underexplored. This study aimed to quantify the real-world effect of semaglutide on perceived food noise.
Study Design
Researchers conducted the INFORM survey, a retrospective assessment among 550 US adults using injectable semaglutide for weight management. Participants were recruited from Numerator's opinion panel and completed 22 multiple-choice questions, including the five-item Food Noise Questionnaire (FNQ). The survey captured self-reported food noise levels both before and after initiating semaglutide, relying on participant recall. Most respondents (86%) had a baseline BMI ≥30 kg/m2 and had used semaglutide for at least 4 months (81%). This cross-sectional design aimed to characterize food noise changes in a real-world population.
Results
Before initiating semaglutide, the median FNQ score was 13 [interquartile range (IQR) 10-16] out of a maximum possible score of 20, indicating substantial food noise. After starting semaglutide, the median FNQ score significantly decreased to 6 (IQR 3-10). The overall median change in FNQ score was -5 (IQR -10, -2), representing a 42% reduction from baseline median. This reduction was consistent across various subgroups, including those defined by treatment duration and baseline BMI. The proportion of participants agreeing or strongly agreeing with statements indicating the presence of food noise fell dramatically from 47-63% before semaglutide to just 15-20% after.
Most respondents (83%) reported high treatment satisfaction, with improvements noted in mental health, self-confidence, lifestyle, and habits since initiating semaglutide. These findings suggest a profound positive impact on the psychological burden associated with food.
Key Findings
- Median 'food noise' (FNQ) score decreased from 13 before semaglutide to 6 after.
- Overall median reduction in FNQ score was -5 (IQR -10, -2).
- Proportion of participants experiencing food noise dropped from 47-63% to 15-20%.
- 83% of respondents reported treatment satisfaction with semaglutide.
- Improvements in mental health, self-confidence, lifestyle, and habits were reported.
Why It Matters
This study highlights that semaglutide's benefits extend beyond mere weight loss, significantly improving the subjective experience of 'food noise' and enhancing overall quality of life. For individuals struggling with persistent food thoughts, this reduction can be transformative, potentially fostering more sustainable dietary habits and better mental well-being. The finding that 83% of users reported treatment satisfaction, alongside improvements in mental health and self-confidence, underscores the broader therapeutic value of GLP-1RAs. While this is a retrospective survey, it provides compelling real-world evidence that could inform patient counseling and treatment expectations. Future prospective studies are needed to fully integrate these findings into clinical protocols, but the implication for current users is clear: semaglutide may offer substantial relief from the mental burden of food-related thoughts, making weight management feel more manageable and less psychologically taxing.
semaglutide
food-noise
obesity
weight-management
glp-1-agonist
survey